NICOLAS THOMAS: Open Payments
NPI 1235892431 · PARIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 28 payments from 9 companies in 2025. Trend: 2023 $304 · 2024 $514 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $145 |
| Novo Nordisk Inc | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Lilly USA, LLC | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: TRELEGY ELLIPTA, SHINGRIX, MOUNJARO, Ozempic, ELIQUIS, REPATHA, BREZTRI, AIRSUPRA.
Industry payments across IL — which companies pay providers there.
